Ikena Oncology Inc expected to post a loss of 42  cents a share - Earnings Preview

ImageneBio

09/05/2022 13:19

* Ikena Oncology Inc  IKNA.OQ   IKNA.O  is expected to show
a rise
in quarterly revenue when it reports  results on May 11
(estimated). 
    * The Boston Massachusetts-based  company is expected to
report  a
31.5% increase in revenue to $4.569 million from $3.47 million a
year ago, according to the mean estimate from 5 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Ikena Oncology Inc
is for
a loss of 42 cents per share. For the same quarter last year,
the company reported a loss of $2.52 per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had fallen by
about 1.6%
in the last three months. ​
    * Wall Street's median 12-month price target for Ikena
Oncology
Inc is $26​, above​ its last closing price of $4.08. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2021  -0.57       -0.51      0.07      Beat    113.7
 Sep. 30 2021  -0.41       -0.42      -0.40     Beat    4.8
 Jun. 30 2021  -0.35       -0.36      -0.35     Beat    1.8​
 Mar. 31 2021  -0.68       -0.68      -2.52     Missed  -271.3
 ​​                                                     
                                                        ​
 This summary was machine generated May 9 at 12:19 GMT.  All
figures in US dollars  unless otherwise stated